B7‐H3 drives immunosuppression and Co‐targeting with CD47 is a new therapeutic strategy in β‐catenin activated melanomas is a research paper published in Pigment Cell & Melanoma Research (2023). On theSindex it has a DataRank of 0. It has been cited 6 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NCI NIH HHS
Grant: P50 CA121974
NIH HHS
Grant: S10 OD030463
NCI NIH HHS
Grant: R01 CA259295
NIH HHS
Grant: S10 OD026880
NIH HHS
Grant: S10 OD018522
National Institutes of Health
Melanoma Research Alliance
FWCI
0.55
Citation Percentile
0.6%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals